iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health, including a virus-like particle (VLP) -based vaccine against SARS-CoV-2. iBio’s subsidiary, iBio CDMO is a global leader in plant-based manufacturing. It’s FastPharming™ and FastGlycaneering™ platforms provide contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. The speed and scalability of FastPharming make it an ideal choice for other innovator companies who want to rapidly produce COVID-19 biologics.

Biotechnology

iBio

Martin Brenner

Tam Phuong

Shuli Wang

Matthew Dent, PhD

Cory Schwartz

Alexander Taguchi

Michael Shassere

Lufei Hu

Brian R. Berquist

Marc Banjak

Felipe Duran

Director Team

Scientific and Research Team

Finance Team

Leadership Team

Teams at iBio

Director Team

Scientific and Research Team

Finance Team

Leadership Team